EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials

Sukh Makhnoon, Fabian Robles, Jessica L Lee, D'Angelo Grant, Marisol Rojas, Ang Gao, Carla Pezzia iD, Venkata Eluri, Navid Sadeghi iD, Song Zhang, Thomas Hulsey, Rebecca Renn und 3 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.71125 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Sukh Makhnoon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Patient Navigation, Clinical Trials as Topic, Patient Selection, Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Cancer Prevention and Research Institute of Texas, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Achieving adequate, timely, and diverse trial enrollment remains a major challenge in clinical research. Insufficiently diverse patient representation compromises the generalizability of clinical trial findings and remains a persistent issue in oncology. Navigation services may help patients learn about clinical trials, identify and overcome barriers, and progress through the care pathway to trial enrollment and retention.

Methods

We implemented a patient navigation program to support diverse enrollment and retention of patients in cancer clinical trials; the proximal outcomes were receipt of financial navigation and trial interest. The study was conducted from July 2023 to July 2024 at two demographically diverse health care settings: a university‐based tertiary healthcare system and an integrated safety‐net healthcare system. Evaluation was guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and incorporated programmatic data, structured surveys of patients and staff, and qualitative patient interviews.

Results

The program navigated 429 oncology patients (52% female, 28% Hispanic/Latino (HL), and 16% non‐HL Black). Compared to the underlying patient population of the clinical settings, program participants were more likely to be Hispanic (31% vs. 21%; p < 0.01), female (52% vs. 48%; p = 0.01) and from a minority race (30% vs. 24%, p ≤ 0.01). Within the population who were successfully contacted, 325 of 408 (92%) patients already enrolled in a trial received financial navigation to help with trial retention. Among the remaining 83 patients not enrolled in a cancer clinical trial at the time of referral, 39 (47%) expressed interest in participating in a clinical trial in thefuture.

Conclusion

A patient navigation program to influence enrollment and retention of diverse patients into trials was feasible to implement, highly acceptable to patients, and reached a priority population of patients generally underrepresented in cancer clinical trials. Further research into the effect of navigation on trial enrollment and retention is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient NavigationClinical Trials as TopicPatient SelectionNeoplasmsPatient ParticipationQualitative ResearchInterviews as TopicTertiary Health CareSafety-net ProvidersAcademic Medical CentersHealth Plan ImplementationEvidence-Based PracticeHumansMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

cancerclinical trialsdiversityimplementation sciencepatient navigation

Autor:innen und Institutionen

  • Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.
  • O'Donnell School of Public Health, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Parkland Health, Dallas, Texas, USA.
  • Biology Department, University of Dallas, Irving, Texas, USA.
  • Division of Hematology-Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Carla Pezzia, Navid Sadeghi, David E Gerber

Förderung

  • NCI NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • American Cancer Society
  • National Cancer Institute

Zitieren

APA

Makhnoon, S., Robles, F., Lee, J. L., Grant, D., Rojas, M., Gao, A., Pezzia, C., Eluri, V., Sadeghi, N., Zhang, S., Hulsey, T., Renn, R., Williams, E. L., Kitzman, H., & Gerber, D. E. (2025). Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials. Cancer Medicine. https://doi.org/10.1002/cam4.71125

Vancouver

Makhnoon S, Robles F, Lee JL, Grant D, Rojas M, Gao A, et al. Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials. Cancer Medicine. 2025. doi:10.1002/cam4.71125

BibTeX
@article{Makhnoon2025,
  author = {Makhnoon, Sukh and Robles, Fabian and Lee, Jessica L and Grant, D'Angelo and Rojas, Marisol and Gao, Ang and Pezzia, Carla and Eluri, Venkata and Sadeghi, Navid and Zhang, Song and Hulsey, Thomas and Renn, Rebecca and Williams, Erin L and Kitzman, Heather and Gerber, David E},
  title = {Implementation of a Patient Navigation Program to Support Representative Participation in Cancer Clinical Trials},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71125}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche